Another study discovered a significant decrease in the expression of SLC16A3 following CTPPPPD administration, indicating that CTPPPPD is involved in cancer and is closely associated with the central carbon metabolism pathway in cancer. The gene discussed is SLC16A3; the disease is cancer.